MedPath

Linked Color Imaging vs White Light Imaging for Detection of Gastric Cancer Precursors

Not Applicable
Completed
Conditions
Early Gastric Cancer
Barrett Esophagus
Interventions
Diagnostic Test: Linked Color Imaging
Diagnostic Test: White Light Imaging
Registration Number
NCT03990025
Lead Sponsor
Changi General Hospital
Brief Summary

This study aims to examine the use of Linked Color Imaging in detection of gastric cancer precursors, as well as oesophageal and duodenal lesions.

Detailed Description

Gastric cancer is the fifth most common cause of death worldwide. Early detection and removal of gastric cancer precursors and early gastric cancer is crucial for good outcomes. However, these lesions are subtle and often missed by conventional white light imaging (WLI) endoscopy. Image enhanced endoscopy techniques have been developed to enhance the detection and characterization of gastrointestinal lesions. Narrow band imaging (NBI) is one such technique. Though widely used, its drawbacks include a limited far view as a result of the optical filter causing a dark endoscopic view. Linked color imaging (LCI) is a more recent image enhanced endoscopy technique that acquires images by using both narrow-band wavelength light and white light in an appropriate balance, enhancing slight color differences in the red region of mucosa. It has been proven to improve detection of H pylori gastritis and colorectal neoplasms. Thus far, there has been no study to determine whether the use of LCI will increase the detection rate of gastric cancer precursors and early gastric cancer compared to WLI. This study aims to determine whether LCI can increase the detection rate of gastric cancer precursors and early gastric cancer when compared to white light endoscopy, with the null hypothesis being no difference in detection rates. This study will also examine the use of LCI with magnification to predict histology findings for focal lesions seen on endoscopy, as well as the use of LCI in identifying esophageal lesions (such as Barett's esophagus) and duodenal lesions.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Patients aged 50 years and above
  • Patients undergoing gastroscopy for symptom evaluation
  • Patients undergoing gastroscopy for surveillance of known intestinal metaplasia
Exclusion Criteria
  • Emergent gastroscopy performed for suspected acute GI bleeding
  • Patients with previous surgical/endoscopic resection in stomach
  • Patients with deranged coagulation and platelet function (INR>1.5, Plt<50)
  • Patients with severe comorbid illness (ASA 3 and above)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
White Light Imaging - Linked Color ImagingLinked Color ImagingParticipant undergoes gastroscopy via White Light Imaging first, then followed by Linked Color Imaging
White Light Imaging - Linked Color ImagingWhite Light ImagingParticipant undergoes gastroscopy via White Light Imaging first, then followed by Linked Color Imaging
Linked Color Imaging - White Light ImagingWhite Light ImagingParticipant undergoes gastroscopy via Linked Color Imaging first, then followed by White Light Imaging
Linked Color Imaging - White Light ImagingLinked Color ImagingParticipant undergoes gastroscopy via Linked Color Imaging first, then followed by White Light Imaging
Primary Outcome Measures
NameTimeMethod
Difference in detection rate of oesophageal lesions between Linked Color Imaging and White Light ImagingImmediately following the procedure

Includes Barrett's Oesophagus, Low Grade Dysplasia, High Grade Dysplasia, Early Oesophageal Cancer

Difference in detection rate of gastric lesions between Linked Color Imaging and White Light ImagingImmediately following the procedure

Includes Intestinal Metaplasia, Gastric Adenoma, Low Grade Dysplasia, High Grade Dysplasia, Early Gastric Cancer

Difference in detection rate of duodenal lesions between Linked Color Imaging and White Light ImagingImmediately following the procedure

Includes Duodenal adenoma, Duodenal adenocarcinoma

Secondary Outcome Measures
NameTimeMethod
Sensitivity and Specificity of detection of gastric lesionsUpon histological confirmation - within 2 weeks of the procedure

Includes Intestinal Metaplasia, Gastric Adenoma, Low Grade Dysplasia, High Grade Dysplasia, Early Gastric Cancer

Sensitivity and Specificity of detection of oesophageal lesionsUpon histological confirmation - within 2 weeks of the procedure

Includes Barrett's Oesophagus, Low Grade Dysplasia, High Grade Dysplasia, Early Oesophageal Cancer

Sensitivity and Specificity of detection of duodenal lesionsUpon histological confirmation - within 2 weeks of the procedure

Includes Duodenal adenoma, Duodenal adenocarcinoma

Trial Locations

Locations (2)

Singapore General Hospital

🇸🇬

Singapore, Singapore

Changi General Hospital

🇸🇬

Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath